These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 20411441)

  • 1. Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.
    Merson TD; Binder MD; Kilpatrick TJ
    Neuromolecular Med; 2010 Jun; 12(2):99-132. PubMed ID: 20411441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia as mediators of inflammatory and degenerative diseases.
    González-Scarano F; Baltuch G
    Annu Rev Neurosci; 1999; 22():219-40. PubMed ID: 10202538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation.
    Kaminska B; Mota M; Pizzi M
    Biochim Biophys Acta; 2016 Mar; 1862(3):339-51. PubMed ID: 26524636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
    Okazaki R; Doi T; Hayakawa K; Morioka K; Imamura O; Takishima K; Hamanoue M; Sawada Y; Nagao M; Tanaka S; Ogata T
    J Neuroinflammation; 2016 Sep; 13(1):235. PubMed ID: 27596241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
    Das Sarma J
    J Neurovirol; 2014 Apr; 20(2):122-36. PubMed ID: 23979705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and Pathophysiological Roles of Transient Receptor Potential Channels in Microglia-Related CNS Inflammatory Diseases.
    Shirakawa H; Kaneko S
    Biol Pharm Bull; 2018; 41(8):1152-1157. PubMed ID: 30068863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.
    van Noort JM; van den Elsen PJ; van Horssen J; Geurts JJ; van der Valk P; Amor S
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):68-81. PubMed ID: 21143143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
    Spitzbarth I; Baumgärtner W; Beineke A
    Vet Immunol Immunopathol; 2012 Jun; 147(1-2):6-24. PubMed ID: 22542984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of glial immune function by neurons.
    Neumann H
    Glia; 2001 Nov; 36(2):191-9. PubMed ID: 11596127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of IL-17 in CNS diseases.
    Waisman A; Hauptmann J; Regen T
    Acta Neuropathol; 2015 May; 129(5):625-37. PubMed ID: 25716179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?
    Tani M; Ransohoff RM
    Brain Pathol; 1994 Apr; 4(2):135-43. PubMed ID: 8061859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of microglia in inflammatory demyelination lesion in the central nervous system].
    Yamasaki R
    Rinsho Shinkeigaku; 2014; 54(12):981-3. PubMed ID: 25672686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia as therapeutic target in central nervous system disorders.
    Fatoba O; Itokazu T; Yamashita T
    J Pharmacol Sci; 2020 Nov; 144(3):102-118. PubMed ID: 32921391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators in demyelinating disorders of the CNS and PNS.
    Hartung HP; Jung S; Stoll G; Zielasek J; Schmidt B; Archelos JJ; Toyka KV
    J Neuroimmunol; 1992 Oct; 40(2-3):197-210. PubMed ID: 1331168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
    Nikodemova M; Watters JJ; Jackson SJ; Yang SK; Duncan ID
    J Biol Chem; 2007 May; 282(20):15208-16. PubMed ID: 17395590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
    Nomura T; Bando Y; You H; Tanaka T; Yoshida S
    Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarization of macrophages and microglia in inflammatory demyelination.
    Cao L; He C
    Neurosci Bull; 2013 Apr; 29(2):189-98. PubMed ID: 23558588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.